Free tool
Healthcare stocks
We cover 24 companies in the Healthcare sector. The median market value in the group is $299.79B. Across the group, the median move over the past trading day is −0.29%. 83% of the 24 with a 200-day average trade above it. Price change over the past year runs from −10.9% to +59.6% across the middle 80 percent of the group, with a median of +24.9%.
Other lists in this group
Table
24 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LILY34.SA | Eli Lilly and Company | $1.10T | Mega cap | +59.83% |
| LLY.DE | Eli Lilly and Company | $1.07T | Mega cap | +73.55% |
| LLY | Eli Lilly and Company | $1.06T | Mega cap | +62.80% |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% |
| JNJB34.SA | Johnson & Johnson | $658.09B | Mega cap | +47.82% |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +32.34% |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% |
| ABBV34.SA | AbbVie Inc. | $467.00B | Mega cap | +21.88% |
| RHO.DE | Roche Holding AG | $370.84B | Mega cap | +41.42% |
| N1VS34.SA | Novartis AG | $301.83B | Mega cap | +20.04% |
| NOT.DE | Novartis AG | $300.14B | Mega cap | +28.89% |
| NVS | Novartis AG | $299.44B | Mega cap | +27.93% |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +5.65% |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +5.09% |
| A1ZN34.SA | AstraZeneca PLC | $258.63B | Mega cap | +0.13% |
| AZN.ST | AstraZeneca PLC | $258.56B | Mega cap | +6.22% |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% |
| NVO.WA | Novo Nordisk A/S | $212.23B | Mega cap | −9.22% |
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | −11.26% |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +15.22% |
| N1VO34.SA | Novo Nordisk A/S | $208.90B | Mega cap | −17.86% |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −13.32% |
| ABL.DE | Abbott Laboratories | $200.44B | Mega cap | −10.02% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.